These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1770160)

  • 1. Fluvoxamine-associated mania/hypomania in patients with obsessive-compulsive disorder.
    Jefferson JW; Greist JH; Perse TL; Rosenfeld R
    J Clin Psychopharmacol; 1991 Dec; 11(6):391-2. PubMed ID: 1770160
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced mania.
    Mundo E; Ronchi P; Bellodi L
    Hosp Community Psychiatry; 1993 Jul; 44(7):689-90. PubMed ID: 8354514
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluvoxamine withdrawal syndrome.
    Szabadi E
    Br J Psychiatry; 1992 Feb; 160():283-4. PubMed ID: 1540778
    [No Abstract]   [Full Text] [Related]  

  • 4. The Osler's view: Treating comorbid bipolar disorder and obsessive-compulsive disorder.
    Amerio A; Tonna M; Odone A; Ghaemi SN
    Aust N Z J Psychiatry; 2017 Sep; 51(9):944-945. PubMed ID: 28747073
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description.
    Diaferia G; Mundo E; Bianchi Y; Ronchi P
    J Clin Psychopharmacol; 1994 Feb; 14(1):78-9. PubMed ID: 8151009
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine for obsessive-compulsive disorder.
    Med Lett Drugs Ther; 1995 Feb; 37(942):13-4. PubMed ID: 7845314
    [No Abstract]   [Full Text] [Related]  

  • 9. Antidepressant-induced mania in obsessive-compulsive disorder.
    Vieta E; Bernardo M
    Am J Psychiatry; 1992 Sep; 149(9):1282-3. PubMed ID: 1503154
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonic reaction associated with fluvoxamine.
    George MS; Trimble MR
    J Clin Psychopharmacol; 1993 Jun; 13(3):220-1. PubMed ID: 8354740
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder.
    Fennig S; Fennig SN; Pato M; Weitzman A
    Br J Psychiatry; 1994 Jun; 164(6):839-41. PubMed ID: 7952995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine treatment of body dysmorphic disorder.
    Hollander E; Cohen L; Simeon D; Rosen J; DeCaria C; Stein DJ
    J Clin Psychopharmacol; 1994 Feb; 14(1):75-7. PubMed ID: 8151008
    [No Abstract]   [Full Text] [Related]  

  • 16. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ; Goodman WK; Leckman JF; Holzer JC; Barr LC; McCance-Katz E; Heninger GR; Price LH
    Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
    Trabert W; Hohagen F; Winkelmann G; Berger M
    Pharmacopsychiatry; 1995 May; 28(3):95-7. PubMed ID: 7568372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage.
    Lenzi A; Raffaelli S; Marazziti D
    Pharmacopsychiatry; 1993 May; 26(3):100-1. PubMed ID: 8415895
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine-induced mania in a patient with obsessive-compulsive disorder.
    Steiner W
    Am J Psychiatry; 1991 Oct; 148(10):1403-4. PubMed ID: 1897626
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.
    Tikka SK; Garg S; Das B
    Indian J Pharmacol; 2013; 45(5):532-3. PubMed ID: 24130396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.